AI assistant
Sending…
Lite Strategy, Inc. — Director's Dealing 2019
Dec 20, 2019
34267_dirs_2019-12-20_9563cdfc-39d3-4548-84c9-845459a8fb11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2019-12-19
Reporting Person: Reynolds Thomas C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-19 | Common Stock | P | 10000 | $1.60 | Acquired | 10000 | Direct |
More from Lite Strategy, Inc.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Feb 17
Interim / Quarterly Report
2026
Feb 17
Director's Dealing
2026
Feb 12
Regulatory Filings
2026
Feb 12
Annual Report
2025
Dec 30
Regulatory Filings
2025
Dec 30
Proxy Solicitation & Information Statement
2025
Dec 30
Regulatory Filings
2025
Dec 30